Positron Emission Tomography as a Method for Measuring Drug Delivery to Tumors in vivo: The Example of [(11)C]docetaxel

por van der Veldt, Astrid A. M., Smit, Egbert F., Lammertsma, Adriaan A.
Publicado 2013

Comment on Cho et al.: Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction

por van der Veldt, Astrid A. M., Lubberink, Mark, Lammertsma, Adriaan A., Smit, Egbert F.
Publicado 2011

A patient perspective on shared decision making in stage I non-small cell lung cancer: a mixed methods study

por Hopmans, Wendy, Damman, Olga C., Senan, Suresh, Hartemink, Koen J., Smit, Egbert F., Timmermans, Danielle R. M.
Publicado 2015

Results of Two Years Expenience with Fluorescence Bronchoscopy in Detection of Preinvasive Bronchial Neoplasia

por Venmans, Ben J. W., Van Boxem, Ton J. M., Smit, Egbert F., Postmus, Pieter E., Sutedja, Tom G.
Publicado 1999

Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells

por Blijlevens, Maxime, Komor, Malgorzata A., Sciarrillo, Rocco, Smit, Egbert F., Fijneman, Remond J. A., van Beusechem, Victor W.
Publicado 2020

Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies

por van Velden, Floris H. P., Cheebsumon, Patsuree, Yaqub, Maqsood, Smit, Egbert F., Hoekstra, Otto S., Lammertsma, Adriaan A., Boellaard, Ronald
Publicado 2011

Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodes

por Borm, Frank J., Smit, Jasper, Bakker, Joyce, Wondergem, Maurits, Smit, Egbert F., de Langen, Adrianus J., de Gruijl, Tanja D.
Publicado 2023

The use of erlotinib in daily practice: a study on adherence and patients' experiences

por Timmers, Lonneke, Boons, Christel CLM, Mangnus, Dirk, Moes, Josee E, Swart, Eleonora L, Boven, Epie, Smit, Egbert F, Hugtenburg, Jacqueline G
Publicado 2011

Why Do Patients and Caregivers Seek Answers From the Internet and Online Lung Specialists? A Qualitative Study

por Schook, Romane Milia, Linssen, Cilia, Schramel, Franz MNH, Festen, Jan, Lammers, Ernst, Smit, Egbert F, Postmus, Pieter E, Westerman, Marjan J
Publicado 2014

Benefit of a Second Opinion for Lung Cancer: No Metastasis to the Kidney but a Synchronous Primary Renal Neoplasm

por ter Avest, Marleen J., Schook, Romane M., Koudstaal, Lyan G., Grünberg, Katrien, Paul, Marinus A., Smit, Egbert F., Postmus, Pieter E.
Publicado 2014

Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical Practice

por Lin, Lishi, Smit, Egbert F., de Langen, Adrianus J., van Balen, Dorieke E. M., Beijnen, Jos H., Huitema, Alwin D. R.
Publicado 2021

Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction

por Schook, Romane M., Koudstaal, Lyan, Comans, Emile F., Postmus, Pieter E., Grünberg, Katrien, Paul, Marinus A., Smit, Egbert F., Sutedja, Thomas G.
Publicado 2014

Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance

por Honeywell, Richard J., Kathmann, Ietje, Giovannetti, Elisa, Tibaldi, Carmelo, Smit, Egbert F., Rovithi, Maria N., Verheul, Henk M.W., Peters, Godefridus J.
Publicado 2020

Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach

por Popat, Sanjay, Navani, Neal, Kerr, Keith M., Smit, Egbert F., Batchelor, Timothy J.P., Van Schil, Paul, Senan, Suresh, McDonald, Fiona
Publicado 2020

A genome‐wide siRNA screen for regulators of tumor suppressor p53 activity in human non‐small cell lung cancer cells identifies components of the RNA splicing machinery as targets...

por Siebring‐van Olst, Ellen, Blijlevens, Maxime, de Menezes, Renee X., van der Meulen‐Muileman, Ida H., Smit, Egbert F., van Beusechem, Victor W.
Publicado 2017

Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment

por de Langen, Adrianus J., Jebbink, M., Hashemi, Sayed M. S., Kuiper, Justine L., de Bruin-Visser, J., Monkhorst, Kim, Thunnissen, Erik, Smit, Egbert F.
Publicado 2018

Response Prediction and Evaluation Using PET in Patients with Solid Tumors Treated with Immunotherapy

por Borm, Frank J., Smit, Jasper, Oprea-Lager, Daniela E., Wondergem, Maurits, Haanen, John B. A. G., Smit, Egbert F., de Langen, Adrianus J.
Publicado 2021

Pilot study of (89)Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer

por Bahce, Idris, Huisman, Marc C, Verwer, Eline E, Ooijevaar, Rogier, Boutkourt, Firdaouss, Vugts, Danielle J, van Dongen, Guus AMS, Boellaard, Ronald, Smit, Egbert F
Publicado 2014

Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study

por Overbeek, Maria J, Groepenhoff, Herman, Voskuyl, Alexandre E, Smit, Egbert F, Peeters, Jochem WL, Vonk-Noordegraaf, Anton, Spreeuwenberg, Marieke D, Dijkmans, Ben C, Boonstra, Anco
Publicado 2008

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

por Lind, Joline S. W., Meijerink, Martijn R., Dingemans, Anne-Marie C., van Kuijk, Cornelis, Öllers, Michel C., de Ruysscher, Dirk, Postmus, Pieter E., Smit, Egbert F.
Publicado 2010